German Center for Lung Research
10
4
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Functional MRI for Monitoring Progression and Assessing Trends in ILD
Role: collaborator
HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening Effort
Role: collaborator
Pediatric Arm of DZL All Age Asthma Cohort
Role: collaborator
Imaging Progression of Chronic Obstructive Pulmonary Disease Using MRI and CT (MR-COPDII)
Role: collaborator
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
Role: collaborator
Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)
Role: collaborator
Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
Role: collaborator
The PROspective German NOn-CF bronchiectaSIS Patient Registry
Role: collaborator
Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis
Role: collaborator
A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools
Role: collaborator
All 10 trials loaded